This site is intended for Healthcare Professionals only.

HRT shortage: “Get your act together, this is just exploitation,” MP lashes out at “profiteering” online pharmacies

Date:

Share post:

Carolyn Harris, Labour MP for Swansea East and co-chair of the Menopause Taskforce, has raised concerns over overcharging of HRT medicines by some online pharmacies, The Telegraph reports.

Carolyn, according to the newspaper, has claimed that some HRT products are being sold online for up to “three times as much as they’re worth”.

She has also accused the companies of “profiteering” from HRT shortage.

Carolyn has vowed to raise this issue in parliament and will also ensure that health secretary Sajid Javid is aware. She also intends to write to Javid to make sure he is up to date with the alleged “profiteering” taking place.

“Get your act together, this is just exploitation. Anybody who thought it was a good idea to hike the price up because there was a shortage… it’s awful, it’s just complete profiteering, and making a profit off the back of somebody’s desperation is never a good look,” she told The Telegraph.

According to screenshots sent to Carolyn one online pharmacy was allegedly advertising the 80 gram pack for £58.98. She told The Telegraph, “last month she paid £62 for four 80 gram packs through another private prescription service. Through an NHS prescription, patients would typically pay £9.35 for one pack.”

The HRT drug shortage has caused chaos in the UK. National media reports have highlighted the problem faced by women in seeking HRT medicines, and how overcharging for the drugs have added to the problem.

To tackle the drug shortage issue, the regulators are also playing their role. Recently Sajid Javid appointed Madelaine McTernan as the new HRT tsar to spearhead efforts to deal with shortages of the medicine.

Last week, DHSC also has issued SSPs on three HRT medicines to limit dispensing supply to three months. To ensure women across the UK will be able to more reliably access HRT products SSPs has been issued on the supply of Oestrogel, Ovestin cream and Premique Low Dose.

DHSC stated: “Women who have a prescription for more than three months but are only able to access three months’ supply will not have to pay an additional prescription charge.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

MHRA outlines strategic approach to AI regulation in healthcare for patient safety

MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity In a...

CCA report highlights success: 90,000 pharmacy first consultations in first two months

The pharmacy first report reveals impressive uptake and patient satisfaction in just two months In a recent report released...

RPS and Pharmacy Support join hands for pharmacy professionals wellbeing

Marks a significant milestone in the pharmacy sector's commitment to nurturing its pharmacy family The Royal Pharmaceutical Society (RPS)...

Atulkumar Patel: A beacon of resilience and innovation in pharmacy practice

Despite offers to join full-time in a GP practice, Patel chose to remain dedicated to his community, becoming...